<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39382809</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1473-4230</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Cerebellum (London, England)</Title><ISOAbbreviation>Cerebellum</ISOAbbreviation></Journal><ArticleTitle>Impact of SARS-CoV-2 Infection on Essential Tremor: A Retrospective Clinical and Kinematic Analysis.</ArticleTitle><Pagination><StartPage>2477</StartPage><EndPage>2486</EndPage><MedlinePgn>2477-2486</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12311-024-01751-5</ELocationID><Abstract><AbstractText>In the past few years, SARS-CoV-2 infection has substantially impacted public health. Alongside respiratory symptoms, some individuals have reported new neurological manifestations or a worsening of pre-existing neurological conditions. We previously documented two cases of essential tremor (ET) who experienced a deterioration in tremor following SARS-CoV-2 infection. However, the effects of SARS-CoV-2 on ET remain largely unexplored. This study aims to evaluate the impact of SARS-CoV-2 infection on a relatively broad sample of ET patients by retrospectively comparing their clinical and kinematic data collected before and after the exposure to SARS-CoV-2. We surveyed to evaluate the impact of SARS-CoV-2 infection on tremor features in ET. Subsequently, we retrospectively analysed clinical and kinematic data, including accelerometric recordings of postural and kinetic tremor. We included 36 ET patients (14 females with a mean age of 71.1&#x2009;&#xb1;&#x2009;10.6 years). Among the 25 patients who reported SARS-CoV-2 infection, 11 (44%) noted a subjective worsening of tremor. All patients reporting subjective tremor worsening also exhibited symptoms of long COVID, whereas the prevalence of these symptoms was lower (50%) in those without subjective exacerbation. The retrospective analysis of clinical data revealed a tremor deterioration in infected patients, which was not observed in non-infected patients. Finally, kinematic analysis revealed substantial stability of tremor features in both groups. The study highlighted a potential correlation between the SARS-CoV-2 infection and clinical worsening of ET. Long COVID contributes to a greater impact of tremor on the daily life of ET patients.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>IRCCS Neuromed, Pozzilli (IS), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grandolfo</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birreci</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelini</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRCCS Neuromed, Pozzilli (IS), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Passaretti</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cannavacciuolo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS Neuromed, Pozzilli (IS), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martini</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Riggi</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paparella</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS Neuromed, Pozzilli (IS), Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fasano</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Division of Neurology, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bologna</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCS Neuromed, Pozzilli (IS), Italy. matteo.bologna@uniroma1.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy. matteo.bologna@uniroma1.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cerebellum</MedlineTA><NlmUniqueID>101089443</NlmUniqueID><ISSNLinking>1473-4222</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020329" MajorTopicYN="Y">Essential Tremor</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001696" MajorTopicYN="N">Biomechanical Phenomena</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061725" MajorTopicYN="N">Accelerometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Essential tremor</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Worsening</Keyword></KeywordList><CoiStatement>Declarations. Ethical Approval: The experimental procedures adhered to the principles of the Declaration of Helsinki and were approved by the local ethics committee. All participants provided informed consent to participate in the study. Competing Interests: The authors declare no competing interests. Financial Interests: The authors declare they have no financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>11</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39382809</ArticleId><ArticleId IdType="pmc">PMC11585502</ArticleId><ArticleId IdType="doi">10.1007/s12311-024-01751-5</ArticleId><ArticleId IdType="pii">10.1007/s12311-024-01751-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021;268(9):3059&#x2013;71. 10.1007/s00415-021-10406-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7826147</ArticleId><ArticleId IdType="pubmed">33486564</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi K, Rai P, Gautam A, et al. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders. Eur J Med Res. 2023;28(1):307. 10.1186/s40001-023-01293-2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10469568</ArticleId><ArticleId IdType="pubmed">37649125</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya A, Kevadiya BD, Gendelman HE, Byrareddy SN. SARS-CoV-2 infection leads to neurological dysfunction. J Neuroimmune Pharmacol off J Soc NeuroImmune Pharmacol. 2020;15(2):167&#x2013;73. 10.1007/s11481-020-09924-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7244399</ArticleId><ArticleId IdType="pubmed">32447746</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N, Di Napoli M, Biller J, et al. The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep. 2021;21(9):44. 10.1007/s11910-021-01130-1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E, Giussani G, Westenberg E, et al. Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions. J Neurol. 2022;269(5):2265&#x2013;74. 10.1007/s00415-021-10848-4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8528941</ArticleId><ArticleId IdType="pubmed">34674005</ArticleId></ArticleIdList></Reference><Reference><Citation>Brola W, Wilski M. Neurological consequences of COVID-19. Pharmacol Rep PR. 2022;74(6):1208&#x2013;22. 10.1007/s43440-022-00424-6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9524739</ArticleId><ArticleId IdType="pubmed">36180640</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683&#x2013;90. 10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho SM, White N, Premraj L, et al. Neurological manifestations of COVID-19 in adults and children. Brain J Neurol. 2023;146(4):1648&#x2013;61. 10.1093/brain/awac332</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494397</ArticleId><ArticleId IdType="pubmed">36087305</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID. Major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;46. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its management. Int J Biol Sci. 2022;18(12):4768&#x2013;80. 10.7150/ijbs.75056</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou MI, Palaiodimou L, Bakola E, et al. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022;13:20406223221076890. 10.1177/20406223221076890</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider, Susanne A, Hennig A, Martino D, et al. Relationship between COVID-19 and movement disorders: a narrative review. Eur J Neurol. 2022;29:1243&#x2013;1253. 10.1111/ene.15217</Citation><ArticleIdList><ArticleId IdType="pubmed">34918437</ArticleId></ArticleIdList></Reference><Reference><Citation>Boura I, Qamar MA, Daddoveri F, et al. SARS-CoV-2 and Parkinson&#x2019;s disease: a review of where we are now. Biomedicines. 2023;11(9):2524. 10.3390/biomedicines11092524</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10526287</ArticleId><ArticleId IdType="pubmed">37760965</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri MA, Bagnato G, Ioppolo C, Versace AG, Irrera N. Impact of the COVID-19 pandemic on chronic neurological disorders: focus on patients with dementia. CNS Neurol Disord Drug Targets. 2022;21(10):1017&#x2013;26. 10.2174/1871527321666220111124928</Citation><ArticleIdList><ArticleId IdType="pubmed">35021982</ArticleId></ArticleIdList></Reference><Reference><Citation>Passaretti M, De Biase A, Paparella G, et al. Worsening of essential tremor after SARS-CoV-2 infection. Cerebellum. 2022;22(1):155&#x2013;8. 10.1007/s12311-022-01366-8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8732967</ArticleId><ArticleId IdType="pubmed">34989982</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa D, Birreci D, Passaretti M, Angelini L, Colella D, Cannavacciuolo A, et al. One-year follow-up on essential tremor worsening after SARS-CoV-2 infection: a series of two cases. Cerebellum. 2023;26. 10.1007/s12311-023-01598-2</Citation><ArticleIdList><ArticleId IdType="pubmed">37632654</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J. Intensification of an essential tremor by SARS-CoV-2. Cerebellum Lond Engl. 2023;22(3):485&#x2013;6. 10.1007/s12311-022-01409-0</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9059111</ArticleId><ArticleId IdType="pubmed">35499810</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia KP, Bain P, Bajaj N, et al. Consensus statement on the classification of tremors. From the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018;33(1):75&#x2013;87. 10.1002/mds.27121</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6530552</ArticleId><ArticleId IdType="pubmed">29193359</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, O&#x2019;Hara ME Hastie C, Roderick P, Yao G, et al. Characteristics and impact of long covid: findings from an online survey. Sutcliffe CG, ed. PLOS ONE. 2022;17(3):e0264331. 10.1371/journal.pone.0264331</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahn S, Tolosa E, Marin C. Clinical rating scale for tremor. Park Dis Mov Disord 1993:225&#x2013;34.</Citation></Reference><Reference><Citation>Paparella G, Angelini L, De Biase A, et al. Clinical and kinematic features of valproate-induced tremor and differences with essential tremor. Cerebellum. 2021;20(3):374&#x2013;83. 10.1007/s12311-020-01216-5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8213593</ArticleId><ArticleId IdType="pubmed">33200286</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biase A, Paparella G, Angelini L, et al. Tremor and movement slowness are two unrelated adverse effects induced by valproate intake. Mov Disord Clin Pract. 2022;9(8):1062&#x2013;73. 10.1002/mdc3.13560</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9631858</ArticleId><ArticleId IdType="pubmed">36339307</ArticleId></ArticleIdList></Reference><Reference><Citation>Bologna M, Berardelli I, Paparella G, et al. Tremor distribution and the variable clinical presentation of essential tremor. Cerebellum. 2019;18(5):866&#x2013;72. 10.1007/s12311-019-01070-0</Citation><ArticleIdList><ArticleId IdType="pubmed">31422549</ArticleId></ArticleIdList></Reference><Reference><Citation>Paparella G, Ferrazzano G, Cannavacciuolo A, et al. Differential effects of propranolol on head and upper limb tremor in patients with essential tremor and dystonia. J Neurol. 2018;265(11):2695&#x2013;703. 10.1007/s00415-018-9052-z</Citation><ArticleIdList><ArticleId IdType="pubmed">30209649</ArticleId></ArticleIdList></Reference><Reference><Citation>Bologna M, Paparella G, Colella D, et al. Is there evidence of bradykinesia in essential tremor? Eur J Neurol. 2020;27(8):1501&#x2013;9. 10.1111/ene.14312</Citation><ArticleIdList><ArticleId IdType="pubmed">32396976</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelini L, Paparella G, De Biase A, et al. Longitudinal study of clinical and neurophysiological features in essential tremor. Eur J Neurol. 2023;30(3):631&#x2013;40. 10.1111/ene.15650</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10107502</ArticleId><ArticleId IdType="pubmed">36437695</ArticleId></ArticleIdList></Reference><Reference><Citation>Deuschl G, Becktepe JS, Dirkx M, et al. The clinical and electrophysiological investigation of tremor. Clin Neurophysiol off J Int Fed Clin Neurophysiol. 2022;136:93&#x2013;129. 10.1016/j.clinph.2022.01.004</Citation><ArticleIdList><ArticleId IdType="pubmed">35149267</ArticleId></ArticleIdList></Reference><Reference><Citation>Janidarmian M, Roshan Fekr A, Radecka K, Zilic Z. A comprehensive analysis on wearable acceleration sensors in human activity recognition. Sensors. 2017;17(3):529. 10.3390/s17030529</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5375815</ArticleId><ArticleId IdType="pubmed">28272362</ArticleId></ArticleIdList></Reference><Reference><Citation>Putzke JD, Whaley NR, Baba Y, Wszolek ZK, Uitti RJ. Essential tremor: predictors of disease progression in a clinical cohort. J Neurol Neurosurg Psychiatry. 2006;77(11):1235&#x2013;7. 10.1136/jnnp.2006.086579</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2077383</ArticleId><ArticleId IdType="pubmed">17043291</ArticleId></ArticleIdList></Reference><Reference><Citation>Benito-Le&#xf3;n J. Essential tremor: a neurodegenerative disease? Tremor Hyperkinetic Mov N Y N. 2014;4:252. 10.7916/D8765CG0</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4107287</ArticleId><ArticleId IdType="pubmed">25120943</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis ED, Bares M, Benito-Leon J, et al. Essential tremor-plus: a controversial new concept. Lancet Neurol. 2020;19(3):266&#x2013;70. 10.1016/S1474-4422(19)30398-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10686582</ArticleId><ArticleId IdType="pubmed">31767343</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Garc&#xed;a D, Oreiro M, P&#xe9;rez P, et al. Impact of Coronavirus disease 2019 pandemic on Parkinson&#x2019;s disease: a cross-sectional survey of 568 Spanish patients. Mov Disord. 2020;35(10):1712&#x2013;6. 10.1002/mds.28261</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436468</ArticleId><ArticleId IdType="pubmed">32776601</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown EG, Chahine LM, Goldman SM, et al. The effect of the COVID-19 pandemic on people with Parkinson&#x2019;s disease. J Park Dis. 2020;10(4):1365&#x2013;77. 10.3233/JPD-202249</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7683050</ArticleId><ArticleId IdType="pubmed">32925107</ArticleId></ArticleIdList></Reference><Reference><Citation>Fearon C, Fasano A. Parkinson&#x2019;s disease and the COVID-19 pandemic. J Park Dis. 2021;11(2):431&#x2013;44. 10.3233/JPD-202320</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8150477</ArticleId><ArticleId IdType="pubmed">33492244</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JE, Kwon KY. Coronavirus disease 2019-associated worsening and improvement of ataxia and gait in a patient with multiple system atrophy. Geriatr Gerontol Int. 2021;21(7):591&#x2013;3. 10.1111/ggi.14184</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239597</ArticleId><ArticleId IdType="pubmed">34008322</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612(7941):758&#x2013;63. 10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidar MA, Shakkour Z, Reslan MA, et al. SARS-CoV-2 involvement in central nervous system tissue damage. Neural Regen Res. 2022;17(6):1228. 10.4103/1673-5374.327323</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8643043</ArticleId><ArticleId IdType="pubmed">34782556</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderheiden A, Klein RS. Neuroinflammation and COVID-19. Curr Opin Neurobiol. 2022;76:102608. 10.1016/j.conb.2022.102608</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9239981</ArticleId><ArticleId IdType="pubmed">35863101</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosentino G, Todisco M, Hota N, et al. Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review. Eur J Neurol. 2021;28(11):3856&#x2013;65. 10.1111/ene.15045</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444743</ArticleId><ArticleId IdType="pubmed">34339563</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietracupa S, Bologna M, Tommasin S, Berardelli A, Pantano P. The contribution of neuroimaging to the understanding of essential tremor pathophysiology: a systematic review. Cerebellum Lond Engl. 2022;21(6):1029&#x2013;51. 10.1007/s12311-021-01335-7</Citation><ArticleIdList><ArticleId IdType="pubmed">34657271</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Madelein AM, Nieuwhof F, Helmich RC. Tremor pathophysiology: lessons from neuroimaging. Curr Opin Neurol. 2020;33(4):474&#x2013;81. 10.1097/WCO.0000000000000829</Citation><ArticleIdList><ArticleId IdType="pubmed">32657888</ArticleId></ArticleIdList></Reference><Reference><Citation>Welton T, Cardoso F, Carr JA, et al. Essential tremor. Nat Rev Dis Primer. 2021;7(1):83. 10.1038/s41572-021-00314-w</Citation><ArticleIdList><ArticleId IdType="pubmed">34764294</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis ED, Gillman A, Boschung S, Hess CW, Yu Q, Pullman SL. High width variability during spiral drawing: further evidence of cerebellar dysfunction in essential tremor. Cerebellum Lond Engl. 2012;11(4):872&#x2013;9. 10.1007/s12311-011-0352-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22230985</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54(1):1473&#x2013;87. 10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Leta V, Rodr&#xed;guez-Violante M, Abundes A, Rukavina K, Teo JT, Falup-Pecurariu C, Irincu L, Rota S, Bhidayasiri R, Storch A, Odin P, Antonini A, Ray Chaudhuri K. Parkinson&#x2019;s disease and PostCOVID-19 syndrome: the Parkinson&#x2019;s long-COVID spectrum. Mov Disord. 2021;36(6):1287&#x2013;9. 10.1002/mds.28622</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250675</ArticleId><ArticleId IdType="pubmed">33890344</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Deleterious outcomes in long-hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome. ACS Chem Neurosci. 2020;11(24):4017&#x2013;20. 10.1021/acschemneuro.0c00725</Citation><ArticleIdList><ArticleId IdType="pubmed">33275404</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A, Shah M, Ahmad SA, et al. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells. 2023;12(5):816. 10.3390/cells12050816</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KWK, Tsung-Ning Huang D, Huang LM. SARS-CoV-2 variants - evolution, spike protein, and vaccines. Biomed J. 2022;45(4):573&#x2013;9. 10.1016/j.bj.2022.04.006</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9072773</ArticleId><ArticleId IdType="pubmed">35526825</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>